Cargando…

Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report

This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaur, Sumit, Torabi, Alireza, O’Neill, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643649/
https://www.ncbi.nlm.nih.gov/pubmed/23691469
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.010
_version_ 1782268348660187136
author Gaur, Sumit
Torabi, Alireza
O’Neill, Thomas J
author_facet Gaur, Sumit
Torabi, Alireza
O’Neill, Thomas J
author_sort Gaur, Sumit
collection PubMed
description This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.
format Online
Article
Text
id pubmed-3643649
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Chinese Anti-Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-36436492013-05-20 Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report Gaur, Sumit Torabi, Alireza O’Neill, Thomas J Cancer Biol Med Case Report This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed. Chinese Anti-Cancer Association 2012-06 /pmc/articles/PMC3643649/ /pubmed/23691469 http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.010 Text en 2012 Cancer Biology & Medicine This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Case Report
Gaur, Sumit
Torabi, Alireza
O’Neill, Thomas J
Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title_full Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title_fullStr Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title_full_unstemmed Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title_short Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
title_sort activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643649/
https://www.ncbi.nlm.nih.gov/pubmed/23691469
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.010
work_keys_str_mv AT gaursumit activityofangiogenesisinhibitorsinmetastaticepithelioidhemangioendotheliomaacasereport
AT torabialireza activityofangiogenesisinhibitorsinmetastaticepithelioidhemangioendotheliomaacasereport
AT oneillthomasj activityofangiogenesisinhibitorsinmetastaticepithelioidhemangioendotheliomaacasereport